FDA Approves First Oral Obesity Pill
Spokane News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Revolutionary Obesity Treatment: The First Oral GLP-1 Pill Approved by FDA
This podcast episode delves into the groundbreaking development of the first oral GLP-1 pill for obesity treatment, marking the end of weekly injections. The pill, which targets the same hormone system as its injectable counterpart, promises to simplify treatment and improve adherence.
Doctors like Ellen Schur from the University of Washington highlight the pills potential to increase accessibility due to its simpler production and shipping process. The medication works by mimicking the guts natural signals to the brain, promoting feelings of fullness and reducing cravings for high-calorie foods.
While the pill is not a quick fix and requires long-term use, early data shows promising results, particularly for diabetes patients who have used similar drugs for years. Side effects are primarily gastrointestinal, and the pill is recommended to be combined with diet and exercise for optimal results.
Despite its potential, cost and insurance gaps continue to limit access for many who need it most. However, the pills simplified production process could help address these issues and make obesity treatment more accessible. Overall, the episode emphasizes the shift towards managing obesity as a chronic condition with science and less stigma, empowering individuals to take control of their health journey.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/b408603eeb46dcbb